ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 93 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 2.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $301,000 | -50.2% | 98,602 | -30.9% | 0.01% | -45.5% |
Q2 2015 | $605,000 | -24.9% | 142,700 | -31.7% | 0.02% | -35.3% |
Q1 2015 | $806,000 | -23.6% | 208,928 | +103.0% | 0.03% | -24.4% |
Q2 2014 | $1,055,000 | +89.7% | 102,900 | +122.2% | 0.04% | +45.2% |
Q1 2014 | $556,000 | -38.4% | 46,316 | -42.0% | 0.03% | -46.6% |
Q4 2013 | $903,000 | -43.4% | 79,833 | -46.1% | 0.06% | -44.2% |
Q3 2013 | $1,595,000 | – | 148,070 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 5,995,760 | $16,129,000 | 1.12% |
Palo Alto Investors LP | 1,425,439 | $3,834,000 | 0.29% |
Granahan Investment Management | 1,438,736 | $3,870,000 | 0.14% |
WealthTrust Axiom LLC | 130,000 | $349,000 | 0.13% |
SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $344,000 | 0.09% |
NIPPON LIFE INSURANCE CO | 17,192 | $2,247,000 | 0.06% |
Joel Isaacson & Co., LLC | 80,660 | $217,000 | 0.05% |
Cornerstone Capital, Inc. | 47,200 | $127,000 | 0.03% |
OXFORD ASSET MANAGEMENT LLP | 153,769 | $414,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $758,000 | 0.01% |